S&P also raised the long-term rating to “AA+” from “AA” on series 1998A tranche 1 and 2 bonds.
Additionally, S&P assigned an “A” rating to Maryland Health and Higher Education Facilities Authority’s series 2017 bonds issued on behalf of MedStar Health, affecting $432 million of rated debt.
Lastly, S&P affirmed the “AA/A-1” rating the health system’s series 1998A tranche 3 bonds issued for MedStar.
S&P analysts attribute the ratings assignment and affirmation to Medstar’s sustainable operating performance and solid balance sheet metrics.
The outlook is stable, reflecting S&P Global Rating’s favorable opinion regarding MedStar’s ability to manage its long-term strategic plan.
More articles on healthcare finance:
4 of 37 provider-sponsored health plans profitable in 2015
Illinois ordered to increase Medicaid funding to providers during budget impasse
Mercy Health Network, AmeriHealth dodge split, helping 220k residents on Medicaid
